1. Home
  2. PDX vs NVAX Comparison

PDX vs NVAX Comparison

Compare PDX & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$21.69

Market Cap

996.5M

Sector

Finance

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.87

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDX
NVAX
Founded
2019
1987
Country
NY
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.5M
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PDX
NVAX
Price
$21.69
$6.87
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$10.78
AVG Volume (30 Days)
N/A
3.9M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
4.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.07
Revenue
N/A
$1,064,651,000.00
Revenue This Year
N/A
$58.91
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.34
Revenue Growth
N/A
20.27
52 Week Low
$13.52
$5.01
52 Week High
$21.05
$11.55

Technical Indicators

Market Signals
Indicator
PDX
NVAX
Relative Strength Index (RSI) 44.78 44.01
Support Level $21.19 $6.56
Resistance Level $22.16 $7.03
Average True Range (ATR) 0.42 0.25
MACD 0.07 0.08
Stochastic Oscillator 50.96 81.33

Price Performance

Historical Comparison
PDX
NVAX

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: